About IGF-1 LR3 0.
IGF-1 LR3 is a synthetic analogue of insulin-like growth factor-1 engineered with amino acid substitutions at positions 3 (Glu→Arg) and an N-terminal extension of 13 amino acids. This modification significantly extends the half-life compared to native IGF-1 by reducing binding affinity to IGF binding proteins. Researchers at Stroid UK Shop investigate this peptide for its role in cellular growth signalling pathways and metabolic regulation studies.
Laboratory Applications
Scientists examine IGF-1 LR3 in various research contexts including cell culture proliferation assays, muscle tissue development studies, and metabolic pathway investigations. The peptide activates IGF-1 receptors with enhanced stability, making it valuable for extended experimental protocols. Researchers studying growth hormone axis interactions often incorporate this compound alongside other research peptides to evaluate synergistic effects. Advanced laboratories also investigate its role in protein synthesis pathways and cellular differentiation mechanisms. The extended biological activity allows for more consistent experimental conditions across multi-day study protocols. Some research teams examine its effects on glucose uptake mechanisms and insulin sensitivity models. The compound’s stability profile makes it particularly suitable for comparative studies against native IGF-1 variants. Investigators studying selective modulators often use IGF-1 LR3 as a reference compound for growth factor signalling research. The peptide’s enhanced bioavailability characteristics provide researchers with improved experimental reproducibility compared to standard IGF-1 preparations.
Specifications
| Molecular Weight | 9117.5 g/mol |
|---|---|
| Sequence Length | 83 amino acids |
| Purity | ≥98% (HPLC verified) |
| Formulation | Lyophilised powder |
| Storage | -20°C (lyophilised), 2-8°C (reconstituted) |
| Solubility | Water, bacteriostatic water |
| CAS Number | Verify with supplier |
| Stability | 24 months (sealed), 30 days (reconstituted) |
Research Compliance
Beligas IGF-1 LR3 0.1mg is manufactured exclusively for in-vitro laboratory research applications. This peptide requires proper handling in controlled research environments with appropriate safety protocols. Storage recommendations must be followed to maintain peptide integrity throughout experimental procedures. Research teams should verify compatibility with their specific IGF-1 research protocols before procurement. This product is not intended for human consumption, therapeutic use, or any application outside legitimate scientific research. All purchases must comply with UK research chemical regulations and institutional research guidelines.
